R Gordon Douglas - Net Worth and Insider Trading

R Gordon Douglas Net Worth

The estimated net worth of R Gordon Douglas is at least $31 dollars as of 2024-04-16. R Gordon Douglas is the Director of Fresh Tracks Therapeutics Inc and owns about 34 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $31. Details can be seen in R Gordon Douglas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Gordon Douglas has not made any transactions after 2016-12-12 and currently still holds the listed stock(s).

Transaction Summary of R Gordon Douglas

To

R Gordon Douglas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R Gordon Douglas owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .

Click here to see the complete history of R Gordon Douglas’s form 4 insider trades.

Insider Ownership Summary of R Gordon Douglas

Ticker Comapny Transaction Date Type of Owner
FRTX Fresh Tracks Therapeutics Inc 2016-12-12 director

R Gordon Douglas Latest Holdings Summary

R Gordon Douglas currently owns a total of 1 stock. R Gordon Douglas owns 34 shares of Fresh Tracks Therapeutics Inc (FRTX) as of December 12, 2016, with a value of $31.

Latest Holdings of R Gordon Douglas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FRTX Fresh Tracks Therapeutics Inc 2016-12-12 34 0.90 31

Holding Weightings of R Gordon Douglas


R Gordon Douglas Form 4 Trading Tracker

According to the SEC Form 4 filings, R Gordon Douglas has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the sale of 32 shares on December 12, 2016, which brought R Gordon Douglas around $24,086.

Insider Trading History of R Gordon Douglas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

R Gordon Douglas Trading Performance

GuruFocus tracks the stock performance after each of R Gordon Douglas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Gordon Douglas is -18.11%. GuruFocus also compares R Gordon Douglas's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Gordon Douglas within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how R Gordon Douglas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of R Gordon Douglas

Average Relative Return

-30.89%

Average relative return per transaction

Outperforming Transactions

33%

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -0.31 -18.11 -39.38 -30.89 -40.91 -42.47
Relative Return to S&P 500(%) 0.91 -21.87 -46.36 -49.3 -56.96 -54.19

R Gordon Douglas Ownership Network

Ownership Network List of R Gordon Douglas

No Data

Ownership Network Relation of R Gordon Douglas


R Gordon Douglas Owned Company Details

What does Fresh Tracks Therapeutics Inc do?

Who are the key executives at Fresh Tracks Therapeutics Inc?

R Gordon Douglas is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .

Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary

Over the past 18 months, R Gordon Douglas made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 209,275 shares, with a net purchase of 209,275 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 386,279 shares were bought by its insiders, resulting in a net purchase of 386,169 shares.

Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fresh Tracks Therapeutics Inc Insider Transactions

No Available Data

R Gordon Douglas Mailing Address

Above is the net worth, insider trading, and ownership report for R Gordon Douglas. You might contact R Gordon Douglas via mailing address: 10390 Pacific Center Court, San Diego Ca 92121.

Discussions on R Gordon Douglas

No discussions yet.